Want to join the conversation?
For full-year 2016, $BSX expects revenue to be in the range of $8.270-8.370Bil, which represents growth of approx. 11-12% YoverY on a reported basis, as well as operational basis. GAAP EPS is expected to be between $0.30-0.35 per share and adjusted EPS, excluding certain items, is expected to be between $1.07-1.11 for full-year 2016.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)